American Well Corporation (AMWL)
Healthcare
- Fundamental
- 3
- Sentiment
- 2
- Technical
- 4
Do Nothing: qualitativeScore is 2 (below the required floor of 3) — the strategy requires qualitativeScore ≥ 3 before any bullish entry and no chart pattern overrides it; independently, the 20-day average dollar volume ($1.28M) is below the $5M liquidity floor and the recent 3-session regular-session average ($1.43M) is below the $1.5M recent-liquidity floor.
Company overview
American Well Corporation provides digital healthcare solutions through its Amwell Platform, enabling hybrid care across various settings. The company offers devices and services to integrate digital care into clinical environments, including specialty care programs and professional services. It serves providers, payers, government, and higher education sectors.
Fundamental
fairStrong liquidity contrasts with revenue contraction and negative profitability, resulting in a mixed fundamental outlook.
Mixed: strong cash runway and sharply improved losses/cash flow, but revenue is contracting and profitability is still meaningfully negative. Valuation looks cheap on EV/Sales due to net cash, yet cash burn and customer-concentration/regulatory risks keep uncertainty high. fundamentalScore = 3/5.
Sentiment
weakSentiment is weak with no significant catalysts or retail interest, and a neutral-to-weak post-earnings reaction.
Sentiment delta is indeterminate — the 14-day sentiment analyzer failed repeatedly on a GNews domain-skip while the 30–90-day baseline sits slightly positive (+0.04) — and the in-window tape reads neutral-to-weak: a Q2 net loss with tightened 2026 loss guidance (announced, 08-04) plus a bearish GF-Value note, with no market-rewarded bullish catalyst to offset it. An imminent Senvest 8.8% stake disclosure (announced, 08-13) has unknown intent and no reception coverage, retail is mention-only, and no red-flag cap applies — a weak, post-event setup with nothing tradeable ahead.
Technical
goodThe stock shows a strong bullish trend, but liquidity and qualitative constraints prevent actionable trades.
Bullish trend structure: price 12.83 above SMA20 (12.39), SMA50 (11.22) and SMA200 (7.15), with EMA9 (12.16) above EMA21 (12.03); ADX14 36.90 and rising confirms a strong trend, and RSI14 61.47 is bullish without being overbought; Williams %R -20.0 near the top of the range. One weak signal: MACD histogram -0.06 (line +0.23 just under signal 0.29) after the multi-week consolidation. Chart quality scores 4, but the trade is blocked by the qualitative floor and thin liquidity, so the score does not translate into an entry.
You’re looking at 2026-09-02 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.